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Abstract
Intestinal metastasis of angiosarcoma is extremely rare. We herein report a case of intestinal perforation due to
intestinal metastasis of angiosarcoma. The patient was a 72-year-old Japanese man with multiple recurrent
angiosarcomas of the scalp. He developed acute abdominal pain with guarding, and we performed an emergency
exploratory laparotomy. An intestinal perforation was found 80 cm from the ligament of Treitz, and partial
jejunectomy was successfully performed. Macroscopic inspection revealed no obvious injury, ulcer, or tumor at or
around the perforation site. Pathological examination revealed angiosarcoma cells penetrating through all layers of
the jejunum at the site of intestinal perforation. This is the first reported case of intestinal perforation caused by
indistinguishable intestinal metastasis of angiosarcoma. This case emphasizes intestinal metastasis of angiosarcoma
as a possible cause of small bowel perforation in patients with advanced angiosarcoma, even when no visible
tumor is present during surgery.
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Background
Angiosarcoma is a very rare tumor that originates from
endothelial cells and constitutes approximately 2 % of
soft tissue sarcomas [1]. Angiosarcoma most commonly
occurs in the cutaneous tissues of the head, neck, and
face, particularly the scalp [2]. The prognosis of this tumor
is poor [1]. The most common sites of recurrence are the
regional lymph nodes and lungs, followed by the liver and
spleen [3].
The incidence of malignant tumors has been increasing
worldwide, and the management of abdominal oncologic
emergencies has thus become more clinically important.
Common causes of abdominal oncologic emergencies are
obstruction, hemorrhage, and perforation. Among these,
intestinal perforation often requires urgent surgical inter-
vention. Lung and gynecologic cancers occasionally cause
intestinal perforation by metastatic tumors [4, 5].
We herein report an extremely rare case of intestinal
perforation due to intestinal metastasis of angiosarcoma,
which was indistinguishable during the operation but
pathologically confirmed after surgery. We also provide
a brief review of the literature regarding intestinal me-
tastasis of angiosarcoma.
Case presentation
A 72-year-old Japanese man presented with recurrent
angiosarcoma. The primary tumor was located on the
scalp and exhibited infiltrative spread with a single
elevated nodule (Fig. 1a, b). He had metastases of the liver
(multiple), lymph nodes (along the left spinal accessory
nerve), bone (fourth thoracic vertebra), and muscle (left
latissimus dorsi). Although the disease was stable with the
first line chemotherapy of triweekly paclitaxel, it was
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discontinued due to a severe peripheral neuropathy. After
the initial course of the second-line chemotherapy using
docetaxel, he exhibited acute abdominal pain. On physical
examination, the patient was pale, diaphoretic, and in
distress due to continuous abdominal pain. He had a
temperature of 36.6 °C, heart rate of 93/min, and blood
pressure of 97/61 mmHg. Significant findings included pale
conjunctiva and hypogastrium tenderness with guarding.
Laboratory examination showed a hemoglobin level of
7.2 g/dL, white blood cell count of 10,100/μL, platelet
count of 587 × 103/μL, and C-reactive protein level of
16.64 mg/dL. Contrast-enhanced computed tomography
showed focal wall thickening of the small intestine
surrounded by ascites and small collections of free air
(Fig. 1c). These findings indicated that the peritonitis had
been caused by intestinal perforation.
We performed an emergency exploratory laparotomy.
A large amount of bloody ascites was observed, although
there were no visible or palpable metastatic tumors in
the peritoneal cavity. Jejunal perforation was found
80 cm from the ligament of Treitz. Intraoperative exam-
ination revealed no obvious injury, ulcer, or tumor at
around the perforation site (Fig. 2a, b). A 50-cm-long
segment of jejunum, including the perforation site, was
surgically removed. End-to-end anastomosis was then
performed by a hand-sewing technique. The patient
began oral ingestion on postoperative day 4, and his
postoperative course was favorable until postoperative
day 8. Hemothorax was suddenly developed on postop-
erative day 9. It was caused by pleural metastasis of
angiosarcoma, because pleural effusion was positive for
angiosarcoma cell. Further surgical intervention was not
considered because of the patient’s unstable condition
due to multiple organ metastases. On postoperative day
23, he died of hemorrhagic shock due to hemothorax.
Pathological examination revealed that the intestinal
perforation was due to a metastatic tumor of angiosarcoma.
On microscopic examination, angiosarcoma cells were
invading through all layers of the jejunum at the
perforation site, which was surrounded by necrotic changes
(Fig. 3a, b). Interestingly, tumor cells were horizontally
infiltrating within the subserosal layer of the jejunum
around the perforation site (Fig. 3c). The tumor cells in the
metastatic region (Fig. 3c) were identical to those at the
primary site (Fig. 1c).
Discussion
To date, only six cases of surgical resection of intes-
tinal metastasis of angiosarcoma have been reported
(Table 1) [3, 6–10]. To the best of our knowledge,
ours is the first case of intestinal perforation due to
macroscopically indistinguishable metastasis of angio-
sarcoma (Table 1).
According to our literature review, hemorrhage is
a common initial symptom in patients with intestinal
metastasis of angiosarcoma. Hemorrhage occurred in
four cases (67 %), but peritonitis occurred in only
Fig. 1 Preoperative findings. a The primary site of angiosarcoma of
the scalp shows infiltrative spread. An arrow shows the nodule. The
tumor is demarcated by the red-brown color (arrowheads). b Tumor
cells from the primary site of the scalp (biopsy specimen). c
Preoperative findings on contrast-enhanced computed tomography.
Focal wall thickening of the small intestine is surrounded by ascites
(arrows), and free air is present (arrowheads)
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two cases (33 %) (Table 1). Ruffolo et al. [3] re-
ported a case of intestinal perforation due to inva-
sion of an ulcerated tumor through all layers of the
small intestine. In the present case, no visible or
palpable ulcerative changes were present on the mu-
cosal or serosal surface of the intestine at or around
the perforation site. Only the pathological examin-
ation revealed intestinal metastasis of angiosarcoma.
Santonja et al. [8] also reported a rare case of intes-
tinal perforation caused by intestinal ischemia due to
tumor cell embolization, but not due to direct intes-
tinal metastasis. In their case, the primary tumor
was located in the abdominal aorta, and the tumor
cells spread into small mesenteric arteries, resulting
in intestinal infarction. In the present case, there
was no evidence of tumor cell embolization on
pathological examination.
The growth pattern of angiosarcoma is usually in-
filtrative, without the formation of a capsule or clear
border distinguishing the tumor from normal tissue.
At the primary site (scalp) in the present case, a
red-brown color was the only clue of demarcation
between the tumor and normal tissue (Fig. 1a). Such
a subtle color change may be more difficult to detect
in a perforated intestine with inflammation than in
the skin. In fact, although many tumor cells were
present within the serosal layer at or around the
perforation site, we found no metastatic changes in
the intestine (Fig. 2a, b). Pathological examination
would be necessary to confirm the presence or ab-
sence of metastatic angiosarcoma of the intestine.
Fig. 3 Pathological findings of resected small intestine. a Macroscopic
cross section and tumor cell mapping (green). An asterisk shows the
site of perforation. c Tumor cells are invading through all layers of the
jejunum with necrotic change. c Tumor cells are horizontally infiltrating
the subserosal layer of the jejunum around the perforation site
Fig. 2 Macroscopic findings of resected small intestine. a No obvious
injury or tumor is present on the serosal surface at or around the
perforation site. b No obvious ulcer or tumor is present on the mucosal
surface at or around the perforation site
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Table 1 Review of reported seven cases (including this case) with intestinal metastasis of angiosarcoma
Authors, year of publication
(reference number)




Visible or tactile tumor
at the site of perforation
Operative procedure Outcome and time after surgery
Schmid E et al.,
1984 [6]
75, M Aorta, bone Terminal ileum Hemorrhage Present
(visible hemorrhage)
Ileocecal resection Dead, approximately 14 months
Kunkel D et al.,
1993 [7]
― Aorta Massive small
intestine
Hemorrhage ― ― ―
Bandorski D et al.,
2002 [9]
75, M Thyroid Massive small
intestine
Hemorrhage ― Multiple jejunal
and ileal resection
―
Hsu JT et al.,
2005 [10]





Ruffolo C et al.,
2004 [3]








(due to respiratory distress)
Santonja C et al.,
2001 [8]




Absent Right ileocolectomy Dead, 18 days
(due to acute renal failure, and liver infarction)
Uchihara et al., 2015
(Current case)[22]







(due to hemorrhagic shock due to hemothorax)











Intestinal perforation during chemotherapy can be
explained by necrotizing enteritis in the presence of neu-
tropenia, metastatic tumor infiltration, and direct intes-
tinal damage by chemotherapeutic agents characterized
by mitotic arrest [11–14]. In the present case, there was
no evidence of neutropenia, enteritis, or any histological
findings of damaged cells with mitotic arrest. Although
we cannot exclude the possibility of tumor necrosis by
chemotherapy, the intestinal perforation in this case may
be due to a metastatic tumor invading the whole wall of
the intestine.
The prognosis of angiosarcoma is very poor. Lahat
et al. reported a median disease-free survival duration of
43 months (range, 1–188 months), a 5-year disease-
specific survival rate of 35 to 40 %, and a median survival
duration of 10 months in patients with metastatic angio-
sarcoma [1, 15–18]. The prognostic factors of angiosar-
coma are reportedly a large tumor (>5 cm) [19, 20], old
age, distant metastasis, and poor performance status
[19, 21]. In our review of seven cases (six previously
reported cases plus ours) of intestinal metastasis from
angiosarcoma, the prognosis of patients with periton-
itis was remarkably poorer than that of patients with
hemorrhage alone. Additional evidence is necessary to
establish the surgical indications for intestinal perfor-
ation due to metastatic angiosarcoma.
Conclusions
In summary, intestinal perforation due to intestinal metas-
tasis of angiosarcoma should be taken into account, in
abdominal emergency cases with advanced angiosarcoma.
Consent
When obtaining an informed consent for surgical proced-
ure, a general consent was also obtained from the patient,
for publication and presentation, as usual.
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